Low-flow anaesthesia is generally considered to be anaesthesia with a fresh gas flow (FGF) of 0.5 to 1l/min (Brattwall et al., 2012). A more recent concept, however, is to use lower flows than those currently used (Hendrickx et al., 2023).
The lowest flows can only be used safely with the appropriate monitoring of inspired and expired gases, which is not readily available in many veterinary practices. This article is aimed as a practical guide to safely deliver lower flows using affordable breathing systems and commonly available monitoring equipment.
The benefits of low-flow anaesthesia in veterinary medicine
There are three main advantages to low-flow anaesthesia:
When it comes to pulse oximetry, the monitoring of adequate haemoglobin O2 concentration in the patient’s arterial blood is essential, aiming for readings of 95% or more.
Capnography, or the monitoring of inspired and expired CO2 levels, gives information about the adequacy of ventilation. Monitors continuously sample gas from the breathing system at rates ranging from 50 to 250ml/min; this loss of gas should be accounted for in the FGF.
Ideally, other inspired and expired gases are monitored – inspired O2 (FiO2), inspired and expired inhalational anaesthetic agent, etc – with an alarm for low FiO2 concentration. This gas monitoring allows more accurate adjustment of the FGF and vaporiser settings, particularly when using flows of under 1l/min.
Although minimum patient O2 requirements are as low as 2 to 3ml/kg/min, in practice flows of at least 0.5 to 1l/min are recommended. This gives more control over the depth of anaesthesia and allows for capnography sampling (up to 250ml/min) and minor leaks.
N2O, largely withdrawn from veterinary anaesthesia due to its environmental impact, is not taken up by the patient, whereas O2 is used for metabolism. As a result, at low flows, O2 (and volatile inhalational agent) concentration within the breathing system gradually reduces. Fresh gases should consist of at least 50 percent O2 (FiO2 over 45 percent where measured), with an FGF of at least 0.5l/min O2 to prevent a hypoxic mix being inspired.
Minimum alveolar concentration (MAC) is the lowest alveolar concentration of the volatile anaesthetic agent that prevents a purposeful movement in response to surgical stimulation in 50 percent of patients. MAC varies in cats and dogs (Table 1) and can be reduced by drugs and regional anaesthesia techniques. As MAC is the alveolar concentration, this closely reflects the end tidal concentration, which can be very different to the vaporiser setting at low flows.
| MACiso | MACsevo | |
|---|---|---|
| Dogs | 1.3 | 2.4 |
| Cats | 1.7 | 3.1 |
In higher-flow anaesthesia, the inspired anaesthetic concentration is closer to the vaporiser concentration setting because a relatively high proportion of the breathing system and patient’s lung volume is replaced by the FGF containing the anaesthetic. In low flows, a smaller volume of fresh gas and anaesthetic agent enters the breathing system, so the inspired concentration may be very different (usually lower) than the vaporiser setting. This is particularly significant at the start of anaesthesia and in larger patients.
Four phases can be considered for low-flow anaesthesia in veterinary practice:
The breathing system and patient lungs contain room air with 21 percent O2. After the induction of anaesthesia and connection to the breathing system, a higher FGF and anaesthetic vaporiser setting is used to rapidly replace the breathing system air with O2 and the anaesthetic agent. Monitoring of the end tidal anaesthetic agent can help guide adjustments of the vaporiser, aiming for a reading closer to the MAC.
| FGF: 2l/min (up to 4l/min in larger dogs) Vaporiser setting: approximately 1.5 times MAC for 5 to 10 mins |
Once the breathing system gases have been largely replaced by O2 and the anaesthetic agent, the FGF can be reduced to 1l/min (or an FGF of 0.5l/min with gas monitoring). As the FGF is lower than the patient’s minute volume, delivered gases will be diluted by the gases in the breathing system. Vaporiser concentrations need to be set higher than the desired end tidal anaesthetic concentration.
| FGF: 1l/min Vaporiser setting: approximately 1 to 1.5 times MAC |
FGF is increased to 2l/min with the vaporiser switched off to replace the breathing system gas with O2.
Increasing the FGF (2l/min or above) with a higher or lower concentration of inhalational agent for a few minutes can be used to increase or decrease the depth of anaesthesia. The reservoir bag contents can also be dumped to change the breathing system gases more rapidly.
An even more rapid increase in anaesthetic depth can be achieved using appropriate boluses of the induction agent.
Circle breathing systems contain components that increase the resistance to breathing and can result in hypoventilation (evident by increased end tidal CO2 levels or increased respiratory effort), particularly in smaller patients.
Manufacturer’s instructions for these systems should be consulted before use in small dogs and cats. Hypoventilation can be minimised by reducing dead space and using smooth internal bore tubing.
Light plane of anaesthesia
Inspired concentrations of the inhalational anaesthetic agent need to be higher with low flows compared to higher flows. This is because the amount of the anaesthetic agent entering the breathing system will be lower and diluted by gases already in the system.
Fresh gases should consist of at least 50 percent O2 with an FGF of at least 0.5l/min O2 to minimise the risk of inspiring a hypoxic gas mixture.
Soda lime contains a dye which changes colour as the granules become exhausted from absorbing CO2. The colour can revert with time, so it is important to replace the absorbent as soon as practicable.
When used with low flows, sevoflurane has been associated with the production of compound A due to a reaction with CO2 absorbents containing potassium or sodium hydroxide. Compound A has been shown to be nephrotoxic in rats, but there is no evidence of toxicity in people (Kennedy et al., 2019).
Datasheets advise against long-duration low-flow sevoflurane anaesthesia, but a recent editorial argues that there is no rationale to support the avoidance of low-flow anaesthesia with sevoflurane (Kennedy et al., 2019).
References (click to expand)